{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T03:18:21Z","timestamp":1783135101367,"version":"3.54.6"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T00:00:00Z","timestamp":1778371200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100014064","name":"University of Salamanca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014064","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.msard.2026.107246","type":"journal-article","created":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T06:57:40Z","timestamp":1778309860000},"page":"107246","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Longitudinal changes in serum protein levels are associated with disability progression in multiple sclerosis"],"prefix":"10.1016","volume":"111","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0738-8100","authenticated-orcid":false,"given":"Luis Sanz","family":"Andreu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Carlos Villoria","family":"Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro Hern\u00e1ndez","family":"Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo Ahumada","family":"Pascual","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta Fiz","family":"Santelesforo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmina El Berdei","family":"Montero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Velasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.msard.2026.107246_bib0001","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12987-025-00748-4","article-title":"Comparative permeability of the blood-brain barrier to albumin, DTPA, and sucrose: effects of inflammation-induced disruption","volume":"23","author":"Banks","year":"2025","journal-title":"Fluids Barriers CNS"},{"issue":"8","key":"10.1016\/j.msard.2026.107246_bib0002","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1093\/brain\/awy154","article-title":"Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis","volume":"141","author":"Barro","year":"2018","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.msard.2026.107246_bib0003","doi-asserted-by":"crossref","first-page":"446","DOI":"10.3390\/jcm8040446","article-title":"K index is a reliable marker of intrathecal synthesis, and an alternative to IgG index in multiple sclerosis diagnostic work-up","volume":"8","author":"Crespi","year":"2019","journal-title":"J Clin Med"},{"issue":"6","key":"10.1016\/j.msard.2026.107246_bib0004","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/ana.24954","article-title":"Serum neurofilament light: a biomarker of neuronal damage in multiple sclerosis","volume":"81","author":"Disanto","year":"2017","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.msard.2026.107246_bib0005","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s41572-018-0041-4","article-title":"Multiple sclerosis","volume":"4","author":"Filippi","year":"2018","journal-title":"Nat Rev Dis Primers"},{"issue":"3","key":"10.1016\/j.msard.2026.107246_bib0006","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S1474-4422(15)00393-2","article-title":"MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines","volume":"15","author":"Filippi","year":"2016","journal-title":"Lancet Neurol"},{"issue":"1","key":"10.1016\/j.msard.2026.107246_bib0007","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-026-47352-6","article-title":"Detection of inflammation-related blood-brain barrier dysfunction using PET and MR imaging: a pilot study","volume":"16","author":"Hilbrig","year":"2026","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.msard.2026.107246_bib0008","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1177\/0271678X221146127","article-title":"Blood-brain barrier disruption measured by albumin index correlates with inflammatory fluid biomarkers","volume":"43","author":"Hillmer","year":"2023","journal-title":"J Cereb Blood Flow Metab"},{"issue":"10","key":"10.1016\/j.msard.2026.107246_bib0009","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000007032","article-title":"Blood neurofilament light chain as a biomarker of MS disease activity and treatment response","volume":"92","author":"Kuhle","year":"2019","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.msard.2026.107246_bib0010","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S1474-4422(22)00289-7","article-title":"Multiple sclerosis progression: time for a new mechanism-driven framework","volume":"22","author":"Kuhlmann","year":"2023","journal-title":"Lancet Neurol"},{"issue":"23","key":"10.1016\/j.msard.2026.107246_bib0011","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000009571","article-title":"Plasma neurofilament light levels are associated with risk of disability in multiple sclerosis","volume":"94","author":"Manouchehrinia","year":"2020","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.msard.2026.107246_bib0012","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0057573","article-title":"Iron is a sensitive biomarker for inflammation in multiple sclerosis lesions","volume":"8","author":"Mehta","year":"2013","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.msard.2026.107246_bib0013","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1007\/s00415-008-0954-z","article-title":"Elevated levels of kappa free light chains in CSF support the diagnosis of multiple sclerosis","volume":"255","author":"Presslauer","year":"2008","journal-title":"J Neurol"},{"issue":"2","key":"10.1016\/j.msard.2026.107246_bib0014","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1056\/NEJMra1401483","article-title":"Multiple sclerosis","volume":"378","author":"Reich","year":"2018","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.msard.2026.107246_bib0015","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol"},{"issue":"14","key":"10.1016\/j.msard.2026.107246_bib0016","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1177\/1352458520970841","article-title":"Rising prevalence of multiple sclerosis worldwide: insights from the Atlas of MS, third edition","volume":"26","author":"Walton","year":"2020","journal-title":"Mult Scler"}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034826002828?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034826002828?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T02:36:56Z","timestamp":1783132616000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034826002828"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":16,"alternative-id":["S2211034826002828"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2026.107246","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Longitudinal changes in serum protein levels are associated with disability progression in multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2026.107246","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107246"}}